Arbutus Biopharma Corp. (ABUS) reported Loss for full year of -$69.92 million
The company's earnings totaled -$69.92 million, or -$0.38 per share. This compares with -$72.85 million, or -$0.44 per share, last year.
The company's revenue for the period fell 66.0% to $6.17 million from $18.14 million last year.
Arbutus Biopharma Corp. earnings at a glance (GAAP) :
-Earnings: -$69.92 Mln. vs. -$72.85 Mln. last year.
-EPS: -$0.38 vs. -$0.44 last year.
-Revenue: $6.17 Mln vs. $18.14 Mln last year.
For comments and feedback: editorial@rttnews.com